The nuclear imaging devices and equipment market has seen considerable growth due to a variety of factors.
• The market for nuclear imaging devices and equipment has seen robust expansion in the past few years. The market, which stood at $4.15 billion in 2024 is projected to increase to $4.43 billion in 2025, growing at a compound annual growth rate (CAGR) of 6.7%.
The surge during the historical period can be linked to the increasing utilization of diagnostic medical imaging, high prevalence of cancer and cardiovascular diseases, and the establishment of more government initiatives.
The nuclear imaging devices and equipment market is expected to maintain its strong growth trajectory in upcoming years.
• The market for nuclear imaging devices and equipment is projected to experience consistent growth over the next several years, expanding to $4.9 billion in 2029 with a compound annual growth rate (CAGR) of 2.5%.
Factors contributing to this growth during the forecast period include increased healthcare spending, a growing elderly population, and elevated healthcare accessibility. Major trends anticipated during this period encompass advancements in positron emission tomography/computed tomography (pet/ct), the creation of cutting-edge spectral detector angio CT solutions, the application of artificial intelligence (AI)-enabled tools, emphasis on the utilisation of the most recent digital technologies, concentration on product innovation, and a focus on forging partnerships and collaborations.
The growth of the nuclear imaging devices and equipment market is anticipated to be driven by the escalating prevalence of chronic diseases. Chronic diseases are essentially prolonged medical conditions that continue for typically more than three months. Nuclear imaging devices and equipment aid in diagnosing and monitoring these enduring ailments by offering vital insights into the advancement of disease, the effectiveness of treatments, and patient care. For example, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, reported in September 2022 that chronic diseases account for 74% of all deaths globally, equating to 41 million deaths annually. This includes 17.9 million from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the nuclear imaging devices and equipment market's growth is being fueled by the rising occurrence of chronic conditions.
The nuclear imaging devices and equipment market covered in this report is segmented –
1) By Product Type: SPECT Systems, PET Systems, Planar Scintigraphy Systems
2) By Application: Oncology, Cardiology, Neurology, Other Applications
3) By End-User: Hospitals, Imaging Centers, Academic & Research Institutes, Other End-Users
Subsegments:
1) By SPECT Systems: Single-Photon Emission Computed Tomography (SPECT) Cameras, Hybrid SPECT/CT Systems, SPECT Probes
2) By PET Systems: Positron Emission Tomography (PET) Scanners, Hybrid PET/CT Systems, PET Probes
3) By Planar Scintigraphy Systems: Gamma Cameras, Dual-Head Gamma Cameras, Single-Head Gamma Cameras
Corporations in the nuclear imaging devices and equipment sector are capitalizing on hybrid imaging advancements like positron emission tomography/computed tomography (PET/CT), single-photon emission computed tomography/computed tomography (SPECT/CT), and positron emission tomography/magnetic resonance imaging (PET/MRI) for nuclear medical imaging purposes. These combined systems produce highly accurate images with enhanced resolution, delivering both anatomic and functional information from a single test. For example, a SPECT/CT system specifically designed for skeletal assessment provides precise localization and heightens the specificity of data supplied by CT.
Major companies operating in the nuclear imaging devices and equipment market include:
• Siemens Healthineers AG
• Koninklijke Philips N.V.
• General Electric Company
• Cardinal Health. Inc
• NTP Radioisotopes SOC Ltd
• SurgicEye GmbH
• Neusoft Medical Systems Co. Ltd
• Digirad Corporation
• Mediso Medical Imaging Systems Ltd
• Shimadzu Corporation
• BCL X-Ray Canada Inc.
• Absolute Imaging Inc.
• Alliar Medicos a Frente
• Clinica da Imagem do Tocantins
• Curium
• DB Diagnosticos do Brasil
• DASA
• Bracco Imaging SpA
• CMR Naviscan Corporation
• Canon Medical Systems Corporation
Western Europe was the largest region in nuclear imaging devices and equipment market in 2024. North America was the second-largest region in nuclear imaging devices and equipment market. The regions covered in the nuclear imaging devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa